Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Why Wegovy's Sales Potential Could Be Massively Understated
Why Wegovy's Sales Potential Could Be Massively Understated
Why Wegovy's Sales Potential Could Be Massively Understated
Submitted by
admin
on August 29, 2023 - 11:08am
Source:
Motley Fool
News Tags:
Novo Nordisk
Wegovy
heart attack
stroke
Headline:
Why Wegovy's Sales Potential Could Be Massively Understated
snippet:
Wegovy may generate more than $4 billion in revenue this year for Novo Nordisk.
A recent study showed the weight-loss drug can also help people bring down their risk of heart attack or stroke.
It's not unreasonable to expect that its peak sales could be in the tens of billions of dollars.
Do Not Allow Advertisers to Use My Personal information